Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georgios Gakis

Showing results (151-160 of 193) with videos related to

Pageof 20
Sort By:
BMC Cancer|April 18, 2015
Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancerTilman Todenhöfer, Jörg Hennenlotter, Philipp Guttenberg, et al.
Central European Journal of Urology|April 28, 2015
Robot-assisted radical cystectomy and intracorporeal urinary diversion - safe and reproducible?Allen Sim, Mevlana Derya Balbay, Tilman Todenhöfer, et al.
Journal of Geriatric Oncology|February 15, 2020
Management of bladder cancer in older patients: Position paper of a SIOG Task ForceNicolas Mottet, Maria J Ribal, Helen Boyle, et al.
World Journal of Surgical Oncology|January 7, 2015
Robot-assisted radical cystectomy and intracorporeal neobladder formation: on the way to a standardized procedureChristian Schwentner, Allen Sim, Mevlana Derya Balbay, et al.
European Urology Focus|May 8, 2021
Receptor Activator of NF Kappa B (RANK) Expression Indicates Favorable Prognosis in Patients with Muscle-invasive Bladder CancerMoritz Maas, Steffen Rausch, Teresa Guttenberg, et al.
European Urology Oncology|May 18, 2019
Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical TrialJ Alfred Witjes, Juan Morote, Erik B Cornel, et al.
Urologia Internationalis|August 21, 2014
Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomyAtiqullah Aziz, Michael Rink, Georgios Gakis, et al.
The Journal of Urology|September 17, 2013
Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomyMichael Rink, Nasim Sharifi, Hans-Martin Fritsche, et al.
Urologic Oncology|May 25, 2012
Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: results from the UroScreen-StudySeverine Banek, Christian Schwentner, Dirk Täger, et al.
World Journal of Urology|October 5, 2011
XPA-210: a new proliferation marker determines locally advanced prostate cancer and is a predictor of biochemical recurrenceStefan Aufderklamm, Jörg Hennenlotter, Tilman Todenhoefer, et al.
Pageof 20

Showing results (151-160 of 193) with videos related to

Sort By:
Pageof 20
BMC Cancer|April 18, 2015
Prognostic relevance of positive urine markers in patients with negative cystoscopy during surveillance of bladder cancerTilman Todenhöfer, Jörg Hennenlotter, Philipp Guttenberg, et al.
Central European Journal of Urology|April 28, 2015
Robot-assisted radical cystectomy and intracorporeal urinary diversion - safe and reproducible?Allen Sim, Mevlana Derya Balbay, Tilman Todenhöfer, et al.
Journal of Geriatric Oncology|February 15, 2020
Management of bladder cancer in older patients: Position paper of a SIOG Task ForceNicolas Mottet, Maria J Ribal, Helen Boyle, et al.
World Journal of Surgical Oncology|January 7, 2015
Robot-assisted radical cystectomy and intracorporeal neobladder formation: on the way to a standardized procedureChristian Schwentner, Allen Sim, Mevlana Derya Balbay, et al.
European Urology Focus|May 8, 2021
Receptor Activator of NF Kappa B (RANK) Expression Indicates Favorable Prognosis in Patients with Muscle-invasive Bladder CancerMoritz Maas, Steffen Rausch, Teresa Guttenberg, et al.
European Urology Oncology|May 18, 2019
Performance of the Bladder EpiCheck™ Methylation Test for Patients Under Surveillance for Non-muscle-invasive Bladder Cancer: Results of a Multicenter, Prospective, Blinded Clinical TrialJ Alfred Witjes, Juan Morote, Erik B Cornel, et al.
Urologia Internationalis|August 21, 2014
Preoperative C-reactive protein in the serum: a prognostic biomarker for upper urinary tract urothelial carcinoma treated with radical nephroureterectomyAtiqullah Aziz, Michael Rink, Georgios Gakis, et al.
The Journal of Urology|September 17, 2013
Impact of preoperative anemia on oncologic outcomes of upper tract urothelial carcinoma treated with radical nephroureterectomyMichael Rink, Nasim Sharifi, Hans-Martin Fritsche, et al.
Urologic Oncology|May 25, 2012
Prospective evaluation of fluorescence-in situ-hybridization to detect bladder cancer: results from the UroScreen-StudySeverine Banek, Christian Schwentner, Dirk Täger, et al.
World Journal of Urology|October 5, 2011
XPA-210: a new proliferation marker determines locally advanced prostate cancer and is a predictor of biochemical recurrenceStefan Aufderklamm, Jörg Hennenlotter, Tilman Todenhoefer, et al.
Pageof 20